Epigral - EPIGRAL, 543332 corporate action history

Epigral Ltd.

NSE: EPIGRAL | BSE: 543332

Mid-range Performer

Download real time

1232.90 -18.20 (-1.45%)

41.68% Fall from 52W High

16,029

NSE+BSE Volume

NSE 25 May, 2026 2:10 PM (IST)

Dividend

Epigral has an upcoming dividend of ₹5.000 per share due on 01 Jun 2026 See details

Epigral Bonus history

Epigral has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Epigral Split history

Epigral has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Epigral

Epigral has declared 6 dividends since Feb. 1, 2023.

In the past 12 months, Epigral has declared an equity dividend amounting to ₹3.50 per share.

At the current share price of ₹1232.9000, Epigral's dividend yield is 0.28%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
01 Jun 2026	5.000	FINAL	01 Jun 2026	Equity Share
20 Jun 2025	3.500	FINAL	21 Jun 2025	Equity Share
07 Feb 2025	2.500	INTERIM	07 Feb 2025	Equity Share
02 Jul 2024	5.000	FINAL	02 Jul 2024	Equity Share
20 Jun 2023	2.500	FINAL	20 Jun 2023	Equity Share
01 Feb 2023	2.500	INTERIM	01 Feb 2023	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Epigral

The latest board meeting for Epigral took place on 02 May 2026, for the purpose of Audited Results & Final Dividend

Ex-Date	Purpose	Notes
02 May 2026	Audited Results & Final Dividend	-
30 Jan 2026	Quarterly Results	-
10 Nov 2025	Quarterly Results	-
02 Aug 2025	Quarterly Results & Fund Raising	-
05 May 2025	Audited Results & Final Dividend	-
27 Jan 2025	Quarterly Results & Interim Dividend	-
09 Nov 2024	Quarterly Results	-
14 Aug 2024	To consider Fund Raising	-
24 Jul 2024	Quarterly Results	-
22 Apr 2024	Audited Results & Final Dividend	-

See all Board Meetings for Epigral

Epigral Rights history

Epigral has not issued any rights since Jan 1, 2000.

See all Rights History for Epigral

VOTE: Is Meghmani Finechem Ltd. worth buying?

99 Votes:

Buy 85.86%

Sell 10.1%

Hold 4.04%